| Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394) |
|---|
| 05/20/2003 | US6566330 Positively charged non-natural amino acids, methods of making and using thereof in peptides |
| 05/15/2003 | US20030092915 Using phase transfer catalyst and quaternary ammonium compound |
| 05/14/2003 | CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same |
| 05/13/2003 | US6562861 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 05/13/2003 | US6562821 For treating arthritis and related disorders, and for treating diseases associated with altered mitochondrial function |
| 05/08/2003 | WO2003037865A1 Novel anticancer compounds |
| 05/08/2003 | CA2468761A1 Novel anticancer compounds |
| 05/07/2003 | EP1307425A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 05/07/2003 | CN1415603A Salt of leonurine and its preparation |
| 05/07/2003 | CN1415602A Method for synthesizing leonurine |
| 05/02/2003 | EP0831799B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders |
| 04/24/2003 | WO2003034071A2 A method of forming a dynamic combinatorial library using a scaffold |
| 04/24/2003 | WO2003033437A2 A method of forming neuraminidase inhibitors by dynamic combinatorial chemistry and compounds obtained |
| 04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/24/2003 | WO2002022553A3 Non-natural basic amino acids, their preparation and use |
| 04/24/2003 | US20030078418 Useful potentiators of beta -lactam antibiotics; therapy |
| 04/23/2003 | EP1304322A2 Carboxylic acid compound and use thereof |
| 04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/22/2003 | US6551614 Antimalarial N,N′-substituted biguanides derived from hydroxylamines |
| 04/17/2003 | WO1998003518A3 New bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity |
| 04/17/2003 | US20030073833 Antiinflammatory agents; anticoagulants |
| 04/17/2003 | US20030073807 Bi-directional synthesis of oligoguanidine transport agents |
| 04/17/2003 | US20030073640 Novel compositions for the delivery of negatively charged molecules |
| 04/16/2003 | EP1301467A2 9-substituted minocycline compounds |
| 04/16/2003 | EP1094812A4 Angiogenesis inhibitors |
| 04/16/2003 | EP0773955B1 New thrombin inhibitors, their preparation and use |
| 04/16/2003 | CN1410419A Method and composition for treating or preventing bacterial infection |
| 04/10/2003 | WO2003029265A1 Inosinie/l-arginine salt and use thereof |
| 04/10/2003 | WO2003029201A1 Methods and compositions for treating or preventing bacterial infection |
| 04/10/2003 | WO2003029198A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same |
| 04/10/2003 | CA2462675A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same |
| 04/10/2003 | CA2460006A1 Methods and compositions for treating or preventing bacterial infection |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/02/2003 | EP1296943A1 Amino acid derivatives and their use as medicines |
| 04/02/2003 | EP1296941A2 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants |
| 04/02/2003 | EP1296931A2 Polyamine analogues as cytotoxic agents |
| 04/01/2003 | US6541497 Hypoglycemic and hypolipidemic compounds |
| 03/27/2003 | WO2003024945A2 Method for producing polyphosphates of organic bases |
| 03/27/2003 | WO2003024921A1 Alkyl urea retinoid agonists i |
| 03/27/2003 | WO2003024920A1 Substituted urea retinoid agonists ii |
| 03/27/2003 | WO2003024407A2 Inhibitors of rnase p proteins as antibacterial compounds |
| 03/27/2003 | WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents |
| 03/26/2003 | EP1296142A2 Calcium receptor active molecules |
| 03/26/2003 | EP1294678A1 Process for the preparation of cationic surfactants |
| 03/26/2003 | EP0885186B1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 03/26/2003 | CN1406226A Novel malonic acid derivatives, process for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them |
| 03/26/2003 | CN1103775C Vitronectin receptor antagonists, their preparation and use |
| 03/20/2003 | US20030055214 Guanidinylation reagents |
| 03/19/2003 | EP1292570A1 Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same |
| 03/18/2003 | US6534546 Aniline derivatives possessing an inhibitory effect of nitric oxide synthase |
| 03/13/2003 | WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 03/13/2003 | US20030050314 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies |
| 03/13/2003 | US20030050251 A polypeptide which inhibits or reduces tumor progression and/or metastasis |
| 03/13/2003 | US20030049310 Genetic enginnering; inducing antibodies |
| 03/12/2003 | EP1289931A1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
| 03/12/2003 | CN1401634A 4-guanidinobenzamides antifertility compounds |
| 03/12/2003 | CN1401633A Process for synthesis of medical biodegradable material in presence of bionic organic guanidine salt catalyst |
| 03/12/2003 | CN1401240A Fungicide, composition thereof, use and fungicidal method thereof |
| 03/06/2003 | US20030045755 Polyamine analogues as cytotoxic agents |
| 03/06/2003 | US20030045556 Aryl-N-cyanoguanidines and methods related thereto |
| 03/06/2003 | US20030044984 1-O-L-arginyl ester 3-O-monoacyl glycerides and 1-O-L-arginyl ester 2,3-O-diacyl glycerides type surface active agents |
| 03/05/2003 | EP1288196A1 Process for the preparation of organo guanidinium salts |
| 03/05/2003 | EP0744396B1 Novel complex salts of phosphoric and amino acids and ruminant feed additive composition containing the same |
| 03/04/2003 | US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 03/04/2003 | US6528507 Arginine salt of 3-(4-(2-(phenoxazin-10-yl)ethoxy) phenyl)-2-ethoxypropanoic acid |
| 02/27/2003 | US20030040544 Antimalarial N,N'-substituted biguanides derived from hydroxylamines |
| 02/26/2003 | EP1285909A1 Process for the production of nitrogen compounds |
| 02/26/2003 | EP1285579A1 Bactericidal guanidine derivatives, dermally applicable composition, washing composition, and antibacterial fibre aggregate |
| 02/26/2003 | EP1284959A1 Compounds for modulating the rage receptor |
| 02/20/2003 | WO2003014076A2 Bi-directional synthesis of oligoguanidine transport agents |
| 02/20/2003 | WO2002053090A3 Medicinal association of a biguanine (metformin) and arginine |
| 02/20/2003 | CA2455951A1 Bi-directional synthesis of oligoguanidine transport agents |
| 02/18/2003 | US6521663 Aminoguanidinyl- and Alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors |
| 02/12/2003 | EP1282602A1 Propanoic acid derivatives as integrin receptor antagonists |
| 02/12/2003 | CN1396908A Palatable arginine compounds and uses thereof for cardiovascular health |
| 02/11/2003 | US6518458 (Aminoiminomethyl) amino) alkane-carboxamides and their applications in therapy |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518309 Microbiocidal properties of poy-substituted guanidinium salts |
| 02/11/2003 | US6518305 Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
| 02/06/2003 | US20030027807 Vitronectin receptor antagonists, their preparation and their use |
| 02/06/2003 | US20030027801 Administering substitued guanidine compounds for therapy of decreased blood flow or nutrient supply to retinal tissue or optic nerve, or retinal ischemia or trauma, or optic nerve injury |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1280766A1 Biocidal polymers based on guanidine salts |
| 02/04/2003 | US6514986 Chiral fluoroquinolone arginine salt forms |
| 01/30/2003 | US20030021773 Arginine mimetics as factor Xa inhibitors |
| 01/29/2003 | EP1192145A4 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| 01/29/2003 | CN1100037C Process for preparing tetramethyl guanidine |
| 01/28/2003 | US6511966 Administering for therapy of mitochondria medited disease |
| 01/23/2003 | WO2003006628A2 Nad synthetase inhibitors and uses thereof |
| 01/22/2003 | CN1392876A Combretastatin A-4 phosphate prodrug, mono-and di-organic amine salt, mono-and di-amino acids salts, and mono-and di-amino acid ester salt |
| 01/21/2003 | US6509497 Process for preparing guanidine derivatives |
| 01/16/2003 | US20030013760 Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/16/2003 | US20030012817 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres. |
| 01/16/2003 | US20030012730 E.g., radiolabelled m-iodobenzylguanidine; polydivinylbenzene-dibutyldichlorostannane product reacted with 1-(3-bomobenzyl)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine; product reacted with cyanamide |
| 01/15/2003 | EP0971886B1 Method for producing n-alkyl-n'-nitroguanidines |
| 01/15/2003 | CN1391473A VLA-4 inhibitor compounds |
| 01/14/2003 | CA2250583C Process for the preparation of n-methyl-d-phenylalanyl-n-¬1-¬3-¬(aminoiminomethyl)amino|propyl|-3,3-difluoro-2-oxohexyl|-l-prolinamide |
| 01/14/2003 | CA2222303C Use of at least one no synthase inhibitor for treating sensitive skin |
| 01/14/2003 | CA2068752C Alkanoyl l-carnitine amides with aminoacids and pharmaceutical compositions containing same for promoting regeneration of the nervous tissue, inhibiting neuronal degeneration, enhancing the processes of learning and memory and for the treatment of coma |
| 01/08/2003 | EP1272458A1 Arginine mimetics as factor xa inhibitors |